STATUTORY RULES.
1965. No. 51.
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1964.*
I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1964.
Dated this 29th
day of April, 1965.
DE L’ISLE
Governor-General.
By His Excellency’s Command,
(Sgd) R. W. Swartz.
Minister of State for Health.
Amendments of the National Health (Pharmaceutical Benefits) Regulations.†
Commencement.
1. These Regulations shall come into operation on the first day of May, 1965.
First, Second, Third, Fourth and Fifth Schedules.
2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—
FIRST SCHEDULE
Regulation 10
Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as, or except as specially provided used in, pharmaceutical Benefits.
Acetomenaphthone.
Acetomenaphthone Tablets.
Acetrizoic Acid.
Alcohol (95%).
Dilute Alcohols.
Dehydrated Alcohol.
Almond Oil.
Amethocaine Hydrochloride
Ammoniated Mercury.
Ammoniated Mercury Ointment.
Amodiaquine Hydrochloride.
Amphetamine Sulphate.
Amylobarbitone Sodium Tablets.
Antazoline Hydrochloride.
Antimony Potassium Tartrate.
Antimony Potassium Tartrate Injection.
Antimony Sodium Tartrate.
Antimony Sodium Tartrate Injection.
Apomorphine Hydrochloride.
Apomorphine Injection.
Bacillus Calmette-Guérin Vaccine.
Bemegride.
Benzhexol Hydrochloride.
Benztropine Methanesulphonate.
Botulinum Antitoxin.
Busulphan.
Butobarbitone.
Calciferol.
Calciferol Solution.
Caramiphen Hydrochloride.
Caraway.
Carbachol.
Carbimazole.
Carbon Dioxide.
* Notified in the Commonwealth Gazette on 30 April 1965
† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; and 1964, Nos. 12, 57 and 135.
3284/65.—Price 6d. 9/30.3.1965.
First Schedule—continued.
Carbromal Tablets.
Cardamom Fruit.
Cascara.
Catgut, Sterilised Surgical.
Cellulose, Oxidised.
Cetylpyridinium Chloride.
Chlorambucil.
Chlorcyclizine Hydrochloride.
Chloroquine Phosphate.
Chloroquine Sulphate.
Chlorothiazide.
Chlorphenesin.
Chlorpropamide.
Chorionic Gonadotrophin.
Chorionic Gonadotrophin Injection.
Cinchocaine Hydrochloride.
Cinnamon.
Citric Acid, Anhydrous.
Cochineal
Colchicine.
Colchicum Corm.
Colchicum Liquid Extract.
Coriander.
Corticotrophin.
Cresol and Soap Solution.
Cresol.
Crotamiton.
Cyanocobalamin.
Cyclizine Tablets.
Cyclobarbitone Calcium.
Cyclomethycaine Sulphate.
Cyclopropane.
Dapsone.
Deoxycortone Trimethylacetate.
Dequalinium Acetate.
Dequalinium Chloride.
Dexamethasone.
Dexamethasone Acetate.
Dexamphetamine Sulphate.
Dextromethorphan Hydrobromide.
Dextromethorphan Tablets.
Diamorphine Hydrochloride.
Diamorphine Injection.
Dibromopropamidine Isethionate.
Dichlorphenamide.
Diethazine Hydrochloride.
Diethylcarbamazine Citrate.
Digitoxin.
Diloxanide Furoate.
Dimenhydrinate.
Dimenhydrinate Injection.
Dimenhydrinate Tablets.
Dimercaprol.
Dimethisterone.
Dimethisterone Tablets.
Diodone Injection.
Diphtheria and Pertussis Vaccine.
Dipipanone Hydrochloride.
Dipipanone Injection.
Domiphen Bromide.
Edrophonium Chloride.
Emetine and Bismuth Iodide.
Emetine Hydrochloride.
Erythromycin.
Ethinyloestradiol
Ethisterone.
Ethopropazine Hydrochloride.
Ethotoin.
Ethyl Chloride.
Ethyl Oleate.
Ethylenediamine Hydrate.
Eugenol.
Fludrocortisone Acetate.
Fluoxymesterone.
Gallamine Triethiodide.
Gallamine Injection.
Gelatin Sponge, Absorbable.
Gentian.
Ginger.
Glutethimide.
Griseofulvin.
Guanethidine Sulphate.
Halothane.
Helium.
Heparin.
Hexamethonium Tartrate.
Hexamethonium Tartrate Injection.
Hexylresorcinol.
Histamine Acid Phosphate.
Human Blood, Whole.
Human Red Blood Corpuscles, Concentrated.
Human Fibrin Foam.
Human Fibrinogen.
Human Gamma Globulin.
Human Gamma Globulin Injection.
Human Plasma, Dried.
Human Serum, Dried.
Human Thrombin.
Hydrallazine Hydrochloride.
Hydrallazine Tablets.
Hydrochlorothiazide.
Hydrocortisone Ointment.
Hydrocortisone Acetate Ointment.
Hydrocortisone Hydrogen Succinate.
Hydroflumethiazide.
Hydrogen Peroxide Solution, Strong.
Hydroxocobalamin.
Hydroxychloroquine Sulphate.
Hyoscyamus.
Imipramine Hydrochloride.
Indigo Carmine.
Influenza Vaccine.
Iodipamide Methylglucamine Injection.
Iodised Oil Fluid Injection.
Iodised Oil Viscous Injection.
Iopanoic Acid.
Iopanoic Acid Tablets.
Iophendylate Injection.
Ipecacuanha, Prepared.
Ipecacuanha and Opium Tablets.
Isoniazid.
Isopropyl Alcohol.
Lead Acetate.
Lead Monoxide.
Lemon Peel, Dried.
Lignocaine Hydrochloride.
Lignocaine and Adrenaline Injection.
First Schedule—continued
Lignocaine Hydrochloride Injection.
Liothyronine Sodium.
Lucanthone Hydrochloride.
Lucanthone Tablets.
Magnesium Stearate.
Male Fern.
Maleic Acid.
Mannitol.
Mecamylamine Hydrochloride.
Melarsoprol.
Menaphthone Sodium Bisulphite.
Mepacrine Hydrochloride.
Mephentermine Sulphate.
Meprobamate.
Meprobamate Tablets.
Mercaptopurine.
Mersalyl Acid.
Methadone Hydrochloride.
Methandienone.
Methoin.
Methyl Hydroxybenzoate.
Methylamphetamine Hydrochloride.
Methylthiouracil.
Methylthiouracil Tablets.
Methyprylone.
Methyprylone Tablets.
Mustine Hydrochloride.
Nalorphine Hydrobromide.
Nandrolone Phenylpropionate.
Naphazoline Hydrochloride.
Neostigmine Bromide.
Nicotinic Acid.
Nikethamide.
Nikethamide Injection.
Nitrous Oxide.
Norethisterone.
Norethisterone Tablets.
Noscapine.
Nux Vomica.
Oestradiol Benzoate.
Opium.
Opium, Powdered.
Orange Peel, Dried Bitter.
Orange Peel, Fresh Bitter.
Oxygen.
Oxytetracycline Dihydrate.
Paramethadione.
Pempidine Tartrate.
Pentamidine Isethionate.
Pentamidine Injection.
Perphenazine.
Perphenazine Tablets.
Pethidine Tablets.
Phanquone.
Phanquone Tablets.
Phenelzine Sulphate.
Phenelzine Tablets.
Phenindamine Tartrate.
Phenindione.
Phenolphthalein Tablets.
Phenolsulphonphthalein.
Phenoxybenzamine Hydrochloride.
Phenoxymethylpenicillin.
Phentolamine Hydrochloride.
Phentolamine Tablets.
Phentolamine Methanesulphonate.
Phentolamine Injection.
Phytomenadione.
Phytomenadione Capsules.
Phytomenadione Tablets.
Picrotoxin.
Piperazine Citrate.
Piperazine Phosphate.
Piperocaine Hydrochloride.
Poliomyelitis Vaccine (Inactivated).
Poliomyelitis Vaccine (Oral).
Potassium Chloride Injection.
Potassium Perchlorate.
Prednisone Acetate.
Primaquine Phosphate.
Primidone.
Probenecid.
Procaine and Adrenaline Injection.
Prochlorperazine Maleate.
Prochlorperazine Methanesulphonate.
Prochlorperazine Tablets.
Procyclidine Hydrochloride.
Progesterone.
Proguanil Hydrochloride.
Promazine Hydrochloride.
Promazine Injection.
Promazine Tablets.
Promethazine Theoclate.
Promethazine Theoclate Tablets.
Propyl Gallate.
Propyl Hydroxybenzoate.
Propyliodone.
Propyliodone Injection.
Propyliodone Oily Injection.
Propylthiouracil.
Pyridostigmine Bromide.
Pyrimethamine.
Quillaia.
Rabies Antiserum.
Rabies Vaccine.
Schick Control.
Senna Leaf.
Sesame Oil.
Soda Lime.
Sodium Acetrizoate Injection.
Sodium Anoxynaphthonate.
Sodium Antimonylgluconate.
Sodium Antimonylgluconate Injection.
Sodium Aurothiomalate.
Sodium Bicarbonate Injection.
Sodium Calciumedetate.
Sodium Chromate (51Cr) Injection.
Sodium Diatrizoate.
Sodium Diatrizoate Injection.
Sodium Fluoride.
Sodium Iodide (131I) Injection.
Sodium Iodide (131I) Solution.
Sodium Lauryl Sulphate.
Sodium Phosphate (32P) Injection.
Sodium Stibogluconate.
Sodium Stibogluconate Injection.
Solapsone.
Solapsone Tablets.
Staphylococcus Antitoxin.
Stibophen.
Stibophen Injection.
Stramonium.
First Schedule—continued
Sulphadimidine Sodium.
Sulphamethizole.
Sulphamethoxypyridazine.
Sulphasomidine.
Sulphasomidine Tablets.
Sulphobromophthalein Sodium.
Suramin.
Suramin Injection.
Suxamethonium Bromide.
Suxamethonium Chloride
Testosterone.
Testosterone Phenylpropionate.
Testosterone Phenylpropionate Injection.
Testosterone Propionate.
Tetrachloroethylene.
Tetrachloroethylene Capsules.
Thiambutosine.
Thiomersal.
Thiopentone Sodium.
Thiopentone Injection.
Thioridazine Hydrochloride.
Thyroid.
Thyroxine Sodium.
Tolazoline Hydrochloride.
Tolbutamide.
Trichloroethylene.
Trifluoperazine Hydrochloride.
Tripelennamine Hydrochloride.
Tryparsamide.
Tryparsamide Injection.
Tuberculin, Old.
Tuberculin Purified Protein Derivative.
Tubocurarine Chloride.
Tubocurarine Injection.
Typhoid-Paratyphoid A and B and Cholera Vaccine.
Typhoid-Paratyphoid A and B and Tetanus Vaccine.
Typhoid-Paratyphoid A, B, and C Vaccine.
Undecenoic Acid.
Vinyl Ether.
Vitamin A Ester Concentrate.
Yellow Fever Vaccine.
Zinc Undecenoate.
Zinc Undecenoate Ointment.
SECOND SCHEDULE
Regulation 10 (3)
Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations
Pharmaceutical Benefits | Allowable Compounds (if any) |
Acrylic Resin................. | — |
Adrenaline Acid Tartrate, B.P...... | — |
Aluminium Powder, B.P.C ........ | Aluminium Powder B.P.C. with Liquid Paraffin B.P. and Zinc Oxide Ointment B.P. |
Aluminium Hydroxide Gel Dried, B.P. | Aluminium Hydroxide Gel Dried B.P. with Magnesium Hydroxide B.P.C. |
| Aluminium Hydroxide Gel Dried B.P. with Magnesium Trisilicate B.P. |
| Aluminium Hydroxide Gel Dried B.P. with Magnesium Carbonate B.P. |
| Aluminium Hydroxide Gel Dried B.P. with Magnesium Trisilicate B.P. and Magnesium Hydroxide B.P.C. |
| Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Aluminium Hydroxide Gel Dried B.P. |
| Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
| Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P. |
Aluminium Sodium Silicate........ | Aluminium Sodium Silicate with Belladonna |
Amphotericin B................ | Tetracycline with a buffering agent and Amphotericin B. |
Aneurine Hydrochloride, B.P....... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Antazoline Sulphate............. | Antazoline Sulphate with Naphazoline Nitrate B.P. |
Second Schedule—continued
Pharmaceutical Benefits | Allowable Compounds (if any) |
Ascorbic Acid, B.P........... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Attapulgite................. | Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P. |
Bacitracin, B.P.............. | Polymyxin B Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P. |
Betamethasone Disodium Phosphate | — |
Betamethasone Phosphate....... | — |
Calcium Lactobionate......... | Thenalidine with Calcium Lactobionate |
Carbinoxamine Maleate........ | — |
Carbromal, B.P.............. | Carbromal B.P., with Pentobarbitone Sodium B.P. |
Chloramine, B.P.C............ | — |
Chloramphenicol, B.P.......... | Chloramphenicol B.P. with Polymyxin B, Sulphate B.P. |
Chlorhexidine Gluconate ....... | — |
Chlorpheniramine Maleate, B.P.... | — |
Chlorpromazine Hydrochloride, B.P. | — |
Chlortetracycline Hydrochloride, B.P. | — |
Clemizole Tannate............ | — |
Cortisone Acetate, B.P.......... | — |
Cymogran................. | — |
Cyproheptadine Hydrochloride... | — |
Cyclizine Hydrochloride, B.P..... | Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P. |
Demecarium Bromide......... | — |
Demethylchlortetracycline Hydrochloride, B.P. | — |
Dexchlorpheniramine Maleate.... | — |
Dextran................... | Dextran with Dextrose B.P. |
| Dextran in Normal Saline |
Dicyclomine Hydrochloride, B.P.C. | — |
Dienoestrol, B.P............. | — |
Digoxin, B.P................ | — |
Dihydrostreptomycin Sulphate, B.P. 1958 | Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P. |
| Dihydrostreptomycin Sulphate B.P. 1958 with Kaolin, Pectin and Aluminium Hydroxide Gel |
Dihydrotachysterol........... | — |
Dimethicone................ | — |
Diphenhydramine Hydrochloride, B.P. | Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P. |
Diphenylpyraline Hydrochloride.. | — |
Diphtheria Vaccine, B.P......... | Diphtheria and Tetanus Vaccine B.P. |
| Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Dyflos, B.P.C............... | — |
Ecothiopate Iodide............ | — |
Entsufon.................. | Hexachlorophane B.P. with Entsufon |
Ergometrine Maleate .......... | Oxytocin with Ergometrine Maleate |
Ergotamine Tartrate, B.P........ | Ergotamine Tartrate B.P. with Caffeine B.P. |
| Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P. |
| Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P. |
| Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P. |
Erythromycin Oral Suspensions... | — |
Ethosuximide ............... | — |
Second Schedule—continued
Pharmaceutical Benefits | Allowable Compounds (if any) |
Ferric Hydroxide............... | — |
Ferrous Aminoacetosulphate....... | — |
Ferrous Gluconate, B.P........... | — |
Ferrous Succinate .............. | — |
Framycetin Sulphate ............ | — |
Galactomin .................. | — |
Glucose Indicator............... | — |
Gramicidin................... | Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin |
Hamamelis Dry Extract, B.P.C...... | Hamamelis Dry Extract B.P.C. with Zinc Oxide, B.P. |
Hexachlorophane, B.P............ | Hexachlorophane B.P. with Entsufon |
| Hexachlorophane B.P. with Lissapol |
| Hexachlorophane B.P. in Soap Solution |
Hydrocortisone, B.P............. | — |
Hydrocortisone Acetate, B.P........ | Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P. |
Ipecacuanha, B.P............... | Phenolphthalein B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P. |
Isoprenaline Hydrochloride ........ | — |
Kanamycin Sulphate, B.P.C. ....... | — |
Levallorphan Tartrate, B.P......... | Levallorphan Tartrate B.P. with Pethidine Hydrochloride B.P. |
Lissapol .................... | Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P. |
| Hexachlorophane B.P. with Lissapol |
Lofenalac ................... | — |
Magnesium Bicarbonate Solution, B.P. 1948 | — |
Magnesium Chloride............ | Ammonium Chloride B.P. with Sodium Chloride B.P., Potassium Chloride B.P. and Magnesium Chloride |
| Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P. |
Mebhydrolin Napadisylate, B.P.C. | — |
Meclozine Hydrochloride, B.P....... | Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P. |
Mepyramine Maleate, B.P......... | — |
Methdilazine Hydrochloride ....... | — |
Methyl Glucamine .............. | Theophylline B.P. with Methyl Glucamine |
Minafen ..................... | — |
Morphine Tartrate .............. | Morphine Tartrate with Tacrine |
Naphazoline Nitrate, B.P.......... | Naphazoline Nitrate B.P. with Antazoline Sulphate |
Neomycin Sulphate, B.P........... | Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P. |
| Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P. |
| Neomycin Sulphate B.P. with Kaolin B.P. |
| Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin |
Neostigmine Methylsulphate, B.P. | — |
Nicotinamide, B.P............... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Nitrofurantoin, B.P.............. | — |
Nystatin, B.P.................. | Tetracycline with a buffering agent and Nystatin B.P. |
Oxytetracycline Hydrochloride, B.P. | Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P. |
Oxytocin.................... | Oxytocin with Ergometrine Maleate |
Pancreatin Enzyme, U.S.N.F. XI .... | — |
Papaveretum, B.P.C.............. | Papaveretum B.P.C. with Hyoscine Hydrobromide B.P. |
Paracetamol, B.P............... | — |
Second Schedule—continued
Pharmaceutical Benefits | Allowable Compounds (if any) |
Penicillin, Benethamine, B.P.C...... | Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P. |
Penicillin, Benzathine, B.P......... | Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P. |
Penicillin, Benzyl, B.P............ | Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P. |
| Fortified Procaine Penicillin Injection B.P. |
| Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. |
Penicillin, Phenoxymethyl (Benzathine, Calcium, Hydrabamine or Potassium Salt or Free Acid) | — |
Penicillin, Potassium, B.P.......... | Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P. |
Penicillin, Procaine, B.P........... | Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P. |
| Fortified Procaine Penicillin Injection B.P. |
| Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P. |
| Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. |
Penicillin, Sodium, B.P........... | Penicillin, Benethamine B.P. with Procaine Penicillin B.P. and Sodium Penicillin B.P. |
Pentolinium Tartrate, B.P.......... | Pentolinium Tartrate B.P. with Ephedrine Hydrochloride B.P. |
Pertussis Vaccine, B.P. ........... | Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Pethidine Hydrochloride, B.P. | Pethidine Hydrochloride B.P. with Levallorphan Tartrate B.P. |
| Pethidine Hydrochloride B.P. with Scopolamine Hydrobromide B.P. |
Phenethicillin Potassium .......... | — |
Pheniramine Maleate ............ | — |
Phenytoin.................... | — |
Pipenzolate Methobromide........ | — |
Pituitary (Posterior Lobe), Powdered, B.P.C. | — |
Polymyxin B. Sulphate, B.P........ | Chloramphenicol B.P. with Polymyxin B. Sulphate B.P. |
| Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P. |
| Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P. |
| Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin |
| Polymyxin B. Sulphate B.P. with Propylene Glycol and Acetic Acid |
Prednisolone, B.P............... | Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P. |
Methylprednisolone, B.P.......... | — |
Prednisolone Sodium Hemisulphate | — |
Prednisolone Sodium Phosphate, B.P.C. | — |
Prednisolone Trimethylacetate, B.P. | — |
Prednisone, B.P................ | Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel B.P. |
Promethazine Hydrochloride, B.P. | — |
Riboflavine, B.P................ | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Senna Fruit, B.P................ | — |
Second Schedule—continued
Pharmaceutical Benefits | Allowable Compounds (if any) |
Silver Nitrate, Toughened, B.P...... |
|
Sobee...................... | — |
Sodium Lactate................ | Sodium Lactate with Potassium Chloride B.P. and Sodium Chloride B.P. |
| Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P. |
| Sodium Lactate with Sodium Chloride B.P. and Dextrose B.P. |
| Sodium Lactate with Sodium Chloride B.P. |
| Sodium Lactate with Potassium Chloride B.P. and Dextrose B.P. |
Sodium Potassium Tartrate, B.P.C. | Compound Effervescent Powder, B.P.C. |
Sodium Tauroglycocholate, B.P.C. 1954 | Sodium Tauroglycocholate B.P.C. 1954 with Cascara Dry Extract B.P. |
Spearmint Oil, B.P.C............. | Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P. |
Strychnine, B.P.C. 1959 .......... | Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine B.P.C. 1959 and Ipecacuanha |
Sulphacetamide, B.P.C............ | Sulphacetamide B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P. |
Sulphadimethoxine, B.P.C......... | — |
Sulphafurazole, B.P.............. | — |
Sulphamerazine, B.P. 1958 ........ | Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphathiazole B.P.C. |
| Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphacetamide B.P.C. |
| Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphadimidine B.P. |
Sulphamethoxydiazine........... | — |
Sulphamethoxypyridazine N-Acetyl | — |
Sulphaphenazole, B.P.C........... | — |
Sulphathiazole, B.P.C............ | Sulphathiazole B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P. |
Surgical Cement............... | — |
Tacrine..................... | Morphine Sulphate B.P. with Tacrine |
| Morphine Tartrate with Tacrine |
Tetanus Vaccine, B.P............. | Diphtheria and Tetanus Vaccine B.P. |
| Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Tetracycline Hydrochloride, B.P..... | Tetracycline Hydrochloride B.P. with a buffering agent |
Tetracycline.................. | Tetracycline with a buffering agent and Amphotericin B. |
| Tetracycline with a buffering agent and Nystatin B.P. |
Thenalidine.................. | Thenalidine with Calcium Lactobionate |
Thenalidine Tartrate ............ | Thenalidine Tartrate with Calcium Lactate B.P. and Calcium Gluconate B.P. |
Theobromine, B.P.C............. | Theobromine B.P.C. with Phenobarbitone B.P. |
Thioridazine ................. | — |
Tragacanth (Gum Karaya) ........ | — |
Trimeprazine Tartrate, B.P.C........ | — |
Triprolidine Hydrochloride, B.P.C. | — |
Vasopressin .................. | — |
Velactin..................... | — |
Viomycin Pantothenate........... | Viomycin Sulphate B.P. with Viomycin Pantothenate |
Viomycin Sulphate, B.P........... | Viomycin Sulphate B.P. with Viomycin Pantothenate |
Viprynium Embonate ............ | — |
Vitamin A ................... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Vitamin D ................... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
THIRD SCHEDULE
Regulation 11
Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia
Acetazolamide Sodium.
Acetohexamide.
Acidified Golden Syrup, A.P.F. 1955.
Acriflavine, B.P.C.
Acrylic Resin.
Adrenaline Hydrochloride.
Adrenaline Mucate.
Agar B.P.C. 1954.
Alkavervir.
Aloin B.P.C.
Almond Oil Volatile Bitter, B.P.C. 1959.
Aloxidone.
Aluminium Acetate Solution, B.P.C.
Aluminium Hydroxide Mixture, A.P.F.
Aluminium Hydroxide Mixture, A.P.F. 1955.
Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex.
Aluminium. Sodium Silicate.
Aluminium Powder, B.P.C.
Amaranth Solution, A.P.F.
Amaranth Solution, Compound, A.P.F.
Amaranth Solution, B.P.C.
Amidopyrine, B.P.C. 1954.
Amitriptyline Hydrochloride.
Ammonia Aromatic Spirit, B.P.C.
Ammonia Solution Strong, B.P.C.
Ammonium Bicarbonate, B.P.C.
Ammonium Bromide, B.P.C.
Amphotericin B.
Ampicillin.
Antazoline Methanesulphonate, B.P.C.
Antazoline Sulphate.
Attapulgite.
Aurothioglucose.
Beclamide.
Beeswax, Yellow, B.P.C.
Belladonna Suppository, B.P. 1948.
Benedict’s Solution, A.P.F.
Benzalkonium Chloride.
Benzoinated Lard, B.P.C. 1954.
Benzoin Compound Tincture, B.P.C.
Benzoin Tincture, B.P.C.
Benzylpenicillin in Oil.
Bephenium Hydroxynaphthoate, B.P.C.
Betamethasone.
Betamethasone Disodium Phosphate.
Betamethasone Phosphate.
Bethanidine Sulphate.
Bismuth Subgallate, B.P.C.
Bretylium Tosylate.
Brown Snake Antivenene.
Buchu Concentrated Infusion, B.P.C. 1954.
Butabarbital Sodium.
Butyl Aminobenzoate, B.P. 1953.
Cade Oil, B.P.C.
Caffeine and Sodium Benzoate, B.P.C. 1954.
Caffeine Citrate, B.P.C. 1959.
Cajuput Spirit, B.P. 1948.
Calamine Cream, A.P.F. 1955.
Calcium Aurothiomalate.
Calcium Di-Oxytetracycline.
Calcium Gluconogalactogluconate.
Calcium Lactobionate.
Calcium Phosphate, B.P.C.
Calumba, Concentrated Infusion, B.P. 1948.
Calumba Tincture, B.P. 1948.
Capsicum Ointment, B.P.C.
Capsicum Tincture, B.P.C.
Carbamazepine.
Carbarsone, B.P.C.
Carbinoxamine Maleate.
Cardamom Aromatic Tincture, B.P.C.
Catechu Tincture, B.P.C.
Cetyl Alcohol Compound.
Chloramine, B.P.C.
Chloramphenicol Palmitate, B.P.C.
Chloramphenicol Stearate.
Chloramphenicol Succinate.
Chlorazanil Hydrochloride.
Chlorhexidine Diacetate.
Chlorhexidine Gluconate.
Chlorobenzol Disulphonamide.
Chlorotrianisene, B.P.C.
Chlorthalidone, B.P.C.
Choline Theophyllinate, B.P.C.
Cinnamon Spirit, B.P.C. 1949.
Cinnamon Water, Concentrated, B.P.C.
Clemizole Hydrochloride.
Clemizole Tannate.
Clopamide.
Clove, Concentrated Infusion, B.P.C. 1954.
Cloxacillin Sodium.
Coal Tar, B.P.C.
Cochineal Tincture, B.P. 1948.
Coconut Oil, B.P.C. 1949.
Codeine, B.P.C. 1954.
Colistin.
Copper Sulphate, B.P.C.
Creosote, B.P.C. 1959.
Cudbear Tincture, A.P.F. 1947.
Curd Soap, B.P.C.
Cyclopenthiazide.
Cyclophosphamide.
Cyclothiazide.
Cycrimine Hydrochloride.
Cymogran.
Cyproheptadine Hydrochloride.
Death Adder Antivenene.
Demecarium Bromide.
Deoxycortone Glucoside.
Desferrioxamine.
Deslanoside.
Dexamethasone Sodium Phosphate.
Third Schedule—continued
Dexchlorpheniramine Maleate.
Dextran.
Dextriferron.
Dicyclomine Hydrochloride, B.P.C.
Digitalis Tincture, B.P.C. 1959.
Dihydroergotamine Methanesulphonate.
Dihydromorphinone Hydrochloride, B.P.C. 1949.
Dihydrostreptomycin Sulphate, B.P. 1958.
Dihydrotachysterol.
Dimethicone, B.P.C.
Diphenylpyraline Hydrochloride.
Dipyridamole.
Disodium Stilboestrol Diphosphate.
Dithiazanine Iodide.
Dyflos, B.P.C.
Ecothiopate Iodide.
Entsufon.
Ephedrine, B.P.C.
Ergot, Liquid Extract, B.P. 1914.
Erythromycin Ethyl Succinate.
Erythromycin Glucoheptonate.
Erythromycin Lactobionate.
Erythromycin Stearate.
Ethanolamine, B.P.C.
Ethanolamine Oleate.
Ether Nitrous Spirit, B.P.C. 1959.
Ethionamide.
Ethosuximide.
Ethoxzolamide.
Ethyl Biscoumacetate, B.P.C.
Ethylidene Dicoumarin.
Ethylnoradrenaline Hydrochloride.
Ethyloestrenol.
Eucalyptol, B.P.C.
Extract of Ox Bile, B.P. 1948.
Ferric Hydroxide.
Ferrous Aminoacetosulphate.
Ferrous Carbonate Saccharated, B.P.C. 1959.
Ferrous Phosphate Compound Syrup, B.P.C.
Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.
Ferrous Succinate.
Folinic Acid.
Framycetin Sulphate.
Frusemide.
Fusidic Acid, Diethanolamine Salt.
Fusidic Acid, Sodium Salt.
Galactomin.
Gall and Opium Ointment, B.P.C.
Gelsemium Tincture, B.P.C.
Glucagon Hydrochloride.
Glucose Indicator.
Glycerophosphate Compound Syrup, A.P.F. 1955.
Goats Milk, dehydrated.
Gramicidin.
Haemophilus Influenzae Bacterial Serum.
Hamamelis Dry Extract, B.P.C.
Hamamelis Liquid Extract, B.P.C.
Heparin Retard.
Hexocyclium Methylsulphate.
Honey, Purified, B.P.C.
Hydrargaphen.
Hydrocyanic Acid, Dilute, B.P.C. 1954.
Hydroxyprogesterone Caproate.
Hyoscine Methobromide.
Hypophosphorous Acid, Dilute, B.P.C.
Idoxuridine.
Indomethacin.
Insulin Injection, specially purified.
Insulin Isophane Injection, specially purified.
Insulin Injection, Special P (Pig).
Iodochlorhydroxyquinoline.
Iodoform, B.P.C. 1954.
Iron Aminoates.
Iron Dextran.
Iron Oxide Saccharated.
Iron Sorbitol Complex.
Isoprenaline Hydrochloride.
Isopropamide Iodide.
Isothipendyl Hydrochloride, B.P.C.
Kanamycin Sulphate, B.P.C.
Kitasamycin.
Lanatoside-C.
Lavender Spike Oil, B.P.C.
Lemon Tincture, B.P. 1958.
Lissapol.
Lobelia Ethereal Tincture, B.P.C.
Lofenalac.
Lypressin.
Magenta, B.P.C.
Magnesium Bicarbonate Solution, B.P. 1948.
Magnesium Chloride.
Magnesium Hydroxide, B.P.C.
Mebhydrolin Napadisylate, B.P.C.
Medroxyprogesterone Acetate.
Mercaptomerin Sodium.
Mestanolone.
Metaraminol Bitartrate.
Metformin Hydrochloride.
Methacycline.
Methazolamide.
Methdilazine Hydrochloride.
Methenamine Mandelate.
Methenolone Acetate.
Methenolone Oenanthate.
Methotrexate.
Methoxamine Hydrochloride, B.P.C.
Methsuximide.
Methyclothiazide.
Methyldopa.
Methyl Glucamine.
Methylphenobarbitone, B.P.C.
Methylprednisolone Acetate.
Metronidazole, B.P.C.
Minafen.
Mitomycin.
Morphine Tartrate.
Myrrh Gum, Powdered, B.P.C.
Myrrh Tincture, B.P.C.
Nalidixic Acid.
Nandrolone Decanoate.
Niclosamide.
Third Schedule— continued
Nicotinyl Alcohol Tartrate.
Nicoumalone.
Nitromin.
Nux Vomica, Dry Extract, B.P.C.
Oestradiol Dipropionate, B.P.C. 1954.
Oestrone, B.P.C. 1954.
Oily Ophthalmic Vehicle, A.P.F. 1955.
Orange Peel Compound, Concentrated Infusion, B.P.C. 1954.
Orange Peel, Concentrated Infusion, B.P.C.
Orciprenaline Sulphate.
Oxymel, B.P.C.
Oxymel of Squill, B.P.C.
Oxymesterone.
Oxyphencyclimine Hydrochloride.
Oxyphenonium Bromide.
Oxytocin.
Pancreatin Enzyme, U.S.N.F. XI.
Papaveretum, B.P.C.
Para-Aminosalicylic Acid.
Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955
Paraben Ophthalmic Vehicle, A.P.F. 1955.
Paraffin Liquid Light, B.P.C.
Paramethasone Acetate.
Pargyline Hydrochloride.
Pectin.
d-Penicillamine Hydrochloride, B.P.C.
Penicillinase.
Penicillin, Benethamine, B.P.C.
Pentaerythritol Tetranitrate, diluted, B.P.C.
Penthienate Methobromide.
Pertussis Vaccine (Haemagglutinin Aluminium Phosphate Adsorbed).
Peru Balsam, B.P.C.
Phenazone, B.P.C.
Phenazopyridine Hydrochloride.
Phenethicillin Potassium.
Phenformin Hydrochloride.
Pheniramine Maleate.
Pheniramine Para-Aminosalicylate.
Phenol Ointment, B.P. 1948.
Phenoxymethylpenicillin, Benzathine.
Phenoxymethylpenicillin, Hydrabamine.
Phensuximide.
Phenytoin.
Phthalylsulphacetamide.
Physostigmine, B.P.C.
Pipenzolate Methobromide.
Pituitary (Posterior Lobe) Powdered, B.P.C.
Polythiazide;
Potable Water.
Potassium Chlorate, B.P.C.
Potassium, Effervescent Tablets.
Prednisolone Sodium Hemisuccinate.
Prednisolone Sodium Hemisulphate.
Prednisolone Sodium Phosphate, B.P.C.
Prednisolone Tertiary Butyl Acetate.
Protoveratrine A.
Pyrazinamide.
Pyridine Aldoxime Methiodide.
Quillaia Tincture, B.P.C.
Quinethazone.
Rauwolfia Alkaloids.
Red Back Spider Antivenene.
Rolitetracycline.
Salicylamide.
Senega, Concentrated Infusion, B.P.C.
Senna Compound Mixture, B.P.C. 1959.
Senna, Concentrated Infusion, B.P.C. 1959.
Senna Fruit Extract (Standardised).
Siberian Fir Oil, B.P.C. 1949.
Silver Protein, B.P.C.
Silver Protein Mild, B.P.C.
Sobee.
Sodium Carbonate Anhydrous, B.P.C.
Sodium Edetate, B.P.C.
Sodium Folate.
Sodium Lactate.
Sodium Nitrite, B.P.C.
Sodium Potassium Tartrate, B.P.C.
Sodium Tauroglycocholate, B.P.C. 1954.
Sorbolene, A.P.F. 1955.
Spearmint Oil, B.P.C.
Spiramycin.
Spironolactone, B.P.C.
Squill Tincture, B.P.C.
Stanolone.
Stearic Acid, B.P.C.
Strophanthus Tincture, B.P. 1948.
Strychnine, B.P.C. 1959.
Sulphacetamide, B.P.C.
Sulphadiazine Sodium, B.P.C.
Sulphadimethoxine, B.P.C.
Sulphaguanidine, B.P.C.
Sulphamerazine, B.P. 1958.
Sulphamethoxydiazine.
Sulphamethoxypyridazine N-Acetyl.
Sulphaphenazole, B.P.C.
Sulphapyridine, B.P.C. 1959.
Sulphasalazine.
Sulphathiazole, B.P.C.
Sulphinpyrazone, B.P.C.
Sulphurated Potash, B.P.C.
Sulphuric Acid, Dilute, B.P.C.
Sulphur Sublimed, B.P.C.
Sultiame.
Surgical Cement.
Sustanon.
Syrup Glucose Liquid, B.P.C.
Tacrine.
Taipan Antivenene.
Tar Ointment, B.P.C. 1959.
Tartrazine, B.P.C. 1954.
Testosterone Oenanthate.
Tetracycline.
Thenalidine.
Thenalidine Tartrate.
Theobromine, B.P.C.
Theobromine and Sodium Salicylate, B.P. 1953.
Theophylline Elixir.
Theophylline Ethanoate of Piperazine.
Thiethylperazine.
Thioridazine.
Thiotepa.
Thyrotrophin.
Tiger Snake Antivenene.
Third Schedule—continued
Tolu Tincture, B.P.C. 1959.
Tragacanth (Gum Karaya).
Tretamine.
Triamcinolone, B.P.C.
Triamterene.
Triaziquone.
Tricyclamol Chloride.
Tridihexethyl Chloride.
Triethanolamine, B.P.C.
Triethanolamine Trinitrate.
Trimeprazine Tartrate, B.P.C.
Trimustine Hydrochloride.
Trinitrophenol, B.P.C. 1959.
Triprolidine Hydrochloride, B.P.C.
Vadrine.
Valerian Ammoniated Tincture, B.P.C.
Vanillin.
Vasopressin Tannate.
Velactin.
Vinblastine Sulphate.
Vincristine Sulphate.
Vinegar of Squill, B.P.C.
Viomycin Pantothenate.
Viprynium Embonate.
Vitamin A.
Vitamin D.
–––––––––––––––––––
FOURTH SCHEDULE
Regulation 12
Additives
Acetone, B.P.C.
Alcohol (95%), B.P.
Dilute Alcohols, B.P.
Amethocaine Hydrochloride, B.P.
Caraway Oil, B.P.C.
Carmine Solution, A.P.F.
Citronella Oil, B.P.C.
Xylene, B.P.C. 1949.
FIFTH SCHEDULE
Regulation 14
Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
Acetylsalicylic Acid Tablets, B.P...... |
|
Soluble Acetylsalicylic Acid Tablets, B.P. |
Any disease or condition in a pensioner |
Compound Acetylsalicylic Acid Tablets, A.P.F. | |
Compound Acetylsalicylic Acid Tablets, B.P.C. | |
Soluble Compound Acetylsalicylic Acid Tablets | |
Acrylic Resin.................. | Ileostomy or colostomy conditions |
Alkavervir.................... | Hypertensive crises |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
Amitriptyline Hydrochloride........ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride |
Amphotericin B................. | Systemic fungal infection |
Ampicillin Capsules ............. | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Ampicillin is the only appropriate antibiotic |
Ampicillin Injections............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Ampicillin Tablets............... | |
Aneurine Hydrochloride Tablets, B.P. | Any disease or condition in a pensioner |
Ascorbic Acid Tablets, B.P.......... |
|
Beclamide .................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Bemegride Injection, B.P........... | As an antidote to barbiturate and other hypnotic poisons |
Bendrofluazide Injection .......... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Betamethasone Tablets ........... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets |
Betamethasone Disodium Phosphate Injection | Intra-articular use |
Bethanidine Sulphate ............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Busulphan Tablets, B.P............ | Leukaemia |
Calciferol Tablets, B.P............. | Any disease or condition in a pensioner |
| With the written authority of the Director-General— |
| Hypoparathyroidism |
| Chronic hypoparathyroid tetany |
| Vitamin D-resistant rickets |
Calcium Aminosalicylate .......... | Tuberculosis |
Calcium Gluconogalactogluconate Effervescent Tablets | Hypoparathyroidism |
Caramiphen Tablets, B.P........... | Parkinsonism |
Carbamazepine ................. | Epilepsy |
| Trigeminal neuralgia |
Chlorambucil Tablets, B.P.......... | Malignant lymphoma and related conditions |
Chloramine Deodorant Tablets and Powder | Ileostomy or colostomy conditions |
Chloramphenicol Capsules, B.P....... | Bacterial meningitis |
| Haemophilus influenzae infections |
| Intra-ocular infections |
| Rickettsial infections |
| Salmonella septicaemia |
| Typhoid and paratyphoid |
| Other serious infections sensitive only to Chloramphenicol |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
|
|
Chloramphenicol Injections ........ |
disease or condition specified in this column in relation to Chloramphenicol Capsules |
Chloramphenicol Tablets .......... | |
Chloramphenicol Oral Suspension | |
Chlorotrianisene Tablets ........... | Carcinoma of the prostate |
Chlorpromazine Hydrochloride ...... | Any disease or condition in a pensioner |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
| With the written authority of the Director-General— |
| Late-stage malignancy |
| Radiation sickness |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride |
Chlortetracycline Capsules, B.P....... | Brucellosis |
| Herpes zoster ophthalmicus |
| Intestinal amoebiasis |
| Leptospirosis |
| Lymphogranuloma venereum |
| Psittacosis |
| Rickettsial infections |
| Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins. |
| Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur |
Chlortetracycline Hydrochloride Granules | A disease or condition, specified in this column in relation to Chlortetracycline Capsules |
Choline Theophyllinate............ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Cloxacillin Sodium .............. | |
Compound Codeine Tablets, B.P...... | |
Compound Codeine Soluble Tablets, B.P. | Any disease or condition in a pensioner |
Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets | |
Codeine Phosphate with Acetylsalicylic Acid Tablets | |
Codeine Phosphate with Acetylsalicylic Acid and Phenacetin Tablets | |
Codeine Phosphate with Acetylsalicylic Acid, Phenacetin and Caffeine Tablets | |
Cod Liver Oil Emulsion ........... | Any disease or condition in a child under the age of twelve years or in a pensioner |
Colistin ...................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
| With the written authority of the Director-General— |
Corticotrophin Injection, B.P...... | A disease or condition specified in this column in relation to Cortisone Injection |
Corticotrophin Gelatin Injection, B.P. | |
Hypsarrhythmia | |
Corticotrophin Zinc Hydroxide Injection, B.P. | Salaam convulsions |
The prevention of side effects of corticosteroid therapy | |
| |
Cortisone Injection, B.P......... | With the written authority of the Director-General— |
| Anaemia, acquired haemolytic |
| Addison’s disease |
| Adrenocortical hypoplasia |
| Adrenalectomy, total |
| Adrenogenital syndrome |
| Agranulocytosis |
| Behcet’s syndrome |
| Cranial arteritis |
| Cushing’s syndrome, including hyperadrenocorticalism |
| Dermatitis, acute exfoliative |
| Dermatomyositis |
| Encephalomyelitis |
| Encephalomyelitis, acute disseminated |
| Guillain-Barré syndrome |
| Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis |
| Hansen’s disease |
| Hepatitis, progressive or continuing, proven by biopsy or biochemistry |
| Hodgkin’s disease |
| Idiopathic hypercalcaemia |
| Inflammatory conditions of the uveal tract and retina |
| Keratoplasty |
| Leucine-sensitive hypoglycaemia |
| Leukaemia |
| Lymphosarcoma and follicular lymphoma |
| Metastatic breast cancer |
| Mycosis fungoides |
| Nephrosis or nephrotic syndrome |
| Neuro-myelitis optica |
| Optic neuritis following removal of tumor of the brain |
| Panhypopituitarism |
| Pemphigus |
| Periarteritis nodosa |
| Progressive transverse myelitis |
| Pseudohermaphroditism |
| Purpura, Henoch’s |
| Purpura, thrombocytopenic |
| Regional ileitis (Crohn’s disease) |
| Reticulum cell sarcoma |
| Rheumatic carditis, acute |
| Sarcoidosis |
| Scleroderma |
| Severe reactions of the skin and mucosa following X-ray therapy |
| Splenic neutropenia |
| Status asthmaticus |
| Steroid therapy prior to operation in patients under steroid therapy |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII. of the Act |
Cortisone Injection, B.P.—continued | Stevens-Johnson syndrome |
| Still’s disease in a child under the age of sixteen years |
| Sympathetic ophthalmitis |
| Systemic lupus erythematosus |
| Temporal arteritis |
| Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases |
| Type II Nephritis |
| Ulcerative colitis proven by sigmoidoscopy or radiological report |
Cortisone Tablets, B.P............. | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Cyanocobalamin Injection, B.P. (other than 1,000 microgram strength) | Established megalocytic anaemia |
Cyanocobalamin Injection, B.P. (1,000 microgram strength) | Neuroblastoma |
| Subacute combined degeneration of the cord |
Cymogran .................... | With the written authority of the Director-General, phenylketonuria |
Cycloserine, B.P................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Cycloserine Capsules, B.P.......... | |
Demethylchlortetracycline Capsules, B.P. | A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus |
Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension | |
Deodorant Detergent Solution (Lissapol with Spearmint Oil and Cetrimide) | Ileostomy or colostomy conditions |
Deoxycortone Aqueous Injections | Addison’s disease |
Deoxycortone Acetate Injection, B.P. | |
Deoxycortone Trimethylacetate Injection, B.P. | |
Adrenalectomy, total | |
Deoxycortone Acetate Implants, B.P. | |
Deoxycortone Acetate Tablets ....... | |
Desferrioxamine ................ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Dexamethasone Tablets, B.P......... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets |
Dexamethasone Sodium Phosphate Injections | Intra-articular use |
Dextran with Dextrose ............ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Dextran in Normal Saline .......... | |
Dienoestrol Cream ............... | Any disease or condition in a pensioner |
Dienoestrol Tablets, B.P............ | Carcinoma of the prostate |
| Mammary carcinoma |
| Any disease or condition in a pensioner |
Dihydrostreptomycin Sulphate Injection | As an alternative to Streptomycin Sulphate in the case of a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate |
Dihydrotachysterol.............. | Parathyroid deficiency |
Diiodohydroxyquinoline Vaginal Tablet | Trichomonal or monilial vaginitis |
Diiodohydroxyquinoline Effervescent Gynaecological Pessary |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
Diloxanide Furoate Tablets, B.P...... | Amoebic dysentery |
Dimethicone .................. | Ileostomy or colostomy conditions |
Disodium Stilboestrol Diphosphate | Carcinoma of the prostate |
Dithiazanine Iodide.............. | Infestations of Trichuris trichiura or Strongyloides stercoralis |
Ditophal..................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Erythromycin .................. | Staphylococcal septicaemia or pneumonia |
| Any gram-positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins |
Ethinyloestradiol Tablets, B.P........ | Turner’s syndrome |
| Pre-menopausal castration syndrome |
| Any disease or condition in a pensioner |
Ethionamide................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Ethisterone Tablets, B.P............ | Turner’s syndrome |
Ethyloestrenol.................. | Mammary carcinoma |
| Senile osteoporosis proven by radiological report |
| With the written authority of the Director-General, long-term corticosteroid therapy |
Fludrocortisone Tablets, B.P......... | Addison’s disease |
| Adrenocortical hypoplasia |
Fluoxymesterone Tablets, B.P........ | Castration syndrome (male and female) |
| Mammary carcinoma |
| With the written authority of the Director-General, long-term corticosteroid therapy |
Folic Acid Injection.............. | Macrocytic anaemia |
Folic Acid Tablets, B.P............ | Sprue or the sprue-like syndrome |
Folinic Acid ................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Framycetin Sulphate Tablets ........ | |
Frusemide .................... | |
Fusidic Acid (Sodium Salt or Diethanolamine Salt) | |
Galactomin ................... | With the written authority of the Director-General, galactosaemia |
Goats Milk, dehydrated ........... | With the written authority of the Director-General, cows milk allergy in children under the age of four years |
Griscofulvin Tablets, B.P........... | With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination |
Halibut Liver Oil Capsules ......... | Any disease or condition in a pensioner |
Haemophilus Influenzae Bacterial Serum | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Hexachlorophane with Entsufon ..... | |
Hexachlorophane with Lissapol ...... | |
Hexachlorophane in Soap Solution | |
Hydrocortisone Injection .......... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Hydrocortisone Acetate Injection, B.P. | Intra-articular use |
Hydrocortisone Sodium Succinate Injection | Acute adrenal failure due to medical or surgical crises |
| Stevens-Johnson syndrome |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
Hydrocortisone Sodium Succinate Soluble Tablet | With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report |
Hydroxocobalamin Injection, B.P. (100 microgram strength) | Established megalocytic anaemia |
Hydroxocobalamin Injection, B.P. (1,000 microgram strength) | Neuroblastoma |
Sub-acute combined degeneration of the cord | |
Hydroxyprogesterone Caproate ...... | Habitual abortion |
Imipramine Tablets, B.P. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride |
Indomethacin .................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Isoniazid Tablets, B.P............. | Tuberculosis |
Kanamycin Sulphate ............. | With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic |
Kitasamycin .................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Levorphanol Tartrate ............. | Obstetrical use |
| Severe intractable pain |
Liothyronine Tablets, B.P........... | Myxoedema |
| Myxoedema coma |
Lofenalac .................... | With the written authority of the Director-General, phenylketonuria |
Medroxyprogesterone Acetate ....... | Endometrial carcinoma |
Mercaptopurine Tablets, B.P......... | Allergic angiitis |
| Leukaemia |
| Lupus erythematosus |
| Periarteritis |
Mestanolone .................. | Mammary carcinoma |
| With the written authority of the Director-General, long-term corticosteroid therapy |
Methacycline .................. | A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus |
Methandienone Tablets, B.P......... | Senile osteoporosis proven by radiological report With the written authority of the Director-General, long-term corticosteroid therapy |
Methenolone Acetate ............. | |
| |
Methenolone Oenanthate .......... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Methicillin Sodium .............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Methicillin Injection, B.P........... | |
Methotrexate Tablets ............. | Leukaemia and neo-plastic disease |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
Methotrexate Injections .......... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Minafen .................... | With the written authority of the Director-General, phenylketonuria |
Mitomycin ................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Morphine Sulphate, B.P. with Tacrine Tablets | Severe intractable pain |
Mustine Injection, B.P............ | Malignant lymphoma and related conditions |
Nalidixic Acid ................ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Nandrolone Phenylpropionate Injection, B.P. | Mammary carcinoma |
Senile osteoporosis proven by radiological report With the written authority of the Director-General, long-term corticosteroid therapy | |
Nandrolone Decanoate ........... | |
Neomycin Sulphate Tablets ........ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Nicotinic Acid Tablets, B.P......... | Any disease or condition in a pensioner |
Nitrofurantoin Tablets, B.P......... | Urinary tract infections |
Nitrofurantoin Oral Suspension ..... | |
Nitromin .................... | Malignant lymphoma and related conditions |
Norethandrolone ............... |
Any disease or condition in a patient receiving treatment in or at an approved hospital |
Norethandrolone Tablets, B.P. ...... | |
Novobiocin Calcium ............ | |
Novobiocin Sodium ............. | |
Novobiocin Tablets, B.P........... | |
Nystatin .................... | Proven monilia infections |
Orciprenaline Sulphate ........... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Oxymesterone ................ | Senile osteoporosis proven by radiological report With the written authority of the Director-General, long-term corticosteroid therapy |
Oxytetracycline Hydrochloride Capsules |
A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus |
Oxytetracycline Tablets, B.P........ | |
Oxytetracycline Hydrochloride Injections | |
Calcium di-Oxytetracycline Oral Suspension | |
Calcium di-Oxytetracycline Paediatric Drops | |
Oxytocin Nasal Spray ........... | Induction of labour |
Pancreatin, B.P. | Fibrocystic disease |
Pancreatin Enzyme U.S.N.F. XI ..... | Pancreatico-duodenectomy |
Pancreatic steatorrhoea | |
Para-Aminosalicylic Acid ......... | Tuberculosis |
Paramethasone Acetate .......... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Paraffin Liquid Emulsion ......... |
|
Paraffin Liquid Emulsion with Phenolphthalein | Any disease or condition in a pensioner |
Pargyline Hydrochloride .......... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Penicillamine ................. | With the written authority of the Director-General, Wilson’s disease (hepatolenticular degeneration) |
Peritoneal Dialysis Solution | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Pethidine Hydrochloride with Levallorphan Tartrate | Obstetrical use |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
Benzylpenicillin with Streptomycin Sulphate | Endocarditis due to Streptococcus faecalis or Streptococcus viridans |
Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate | |
Phenacetin with Codeine Phosphate and Pentobarbitone Sodium | Any disease or condition in a pensioner |
Phytomenadione Injection, B.P....... | Antidote to anticoagulants |
Pituitary, Posterior Lobe, Insufflation | Diabetes insipidus |
Polymyxin B. Sulphate Injection ..... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Prednisolone Sodium Phosphate Retention Enema | With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report |
Prednisolone Tablets, B.P........... | With the written authority of the Director-General— |
| Nodular non-suppurative panniculitis (Christian-Weber disease) |
| A disease or condition specified in this column in relation to Cortisone Injection except Total adrenalectomy, Addison’s disease or adrenocortical hypoplasia |
Prednisolone Acetate Injection ...... |
|
Prednisolone Methyl Acetate Injections | Intra-articular use |
Prednisolone Tertiary Butyl Acetate Injection | |
Prednisolone Trimethylacetate Injections | |
Methylprednisolone Tablets, B.P...... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets |
Methylprednisolone Capsules ....... | |
Prednisolone with Magnesium Trisilicate and Dried Aluminium Hydroxide Gel | |
Prednisolone Sodium Hemisuccinate | With the written authority of the Director-General, medical or surgical crises |
Prednisone Tablets, B.P............ | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets |
Prednisone with Magnesium Trisilicate and Dried Aluminium Hydroxide Gel | |
Progesterone .................. | Habitual abortion |
Protoveratrine A ................ | Hypertensive crises |
Pyrazinamide .................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Pyridostigmine Injection, B.P........ | |
Pyridostigmine Tablets, B.P......... | |
Pyridoxine Hydrochloride Tablets | Peripheral neuritis due to isoniazid therapy Radiation sickness |
Riboflavine Tablets .............. | Any disease or condition in a pensioner |
Senna Fruit Extract (Standardized) | |
Sobee ....................... | With the written authority of the Director-General— |
| Galactosaemia |
| Lactose intolerance |
| Milk allergy in children under the age of four years |
Sodium Aminosalicylate .......... | Tuberculosis |
Sodium Folate ................. | Macrocytic anaemia |
| Sprue or the sprue-like syndrome |
Spiramycin ................... | A disease or condition specified in this column in relation to Erythromycin |
Spironolactone ................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
Stanolone .................... | Mammary carcinoma |
| With the written authority of the Director-General, long-term corticosteroid therapy |
Stilboestrol Injection ............. | Carcinoma of the prostate |
Stilboestrol Tablets, B.P............ | Mammary Carcinoma |
Any disease or condition in a pensioner | |
Streptomycin Sulphate Injections ..... | Bacillary dysentery that is resistant to the Sulphonamides |
| Brucellosis |
| Chancroid |
| Endocarditis due to Streptococcus faecalis or Streptococcus viridans |
| Friedlander bacillus infections |
| Haemophilus influenzae infections |
| Plague |
| Pseudomonas pyocyanea infections |
| Rat-bite fever (Streptobacillus moniliformis) |
| Salmonella infections |
| Surgical conditions of the bowel (pre-operative and post-operative) |
| Surgical conditions of the thoracic organs |
| Tuberculosis |
| Tularaemia |
| Urinary tract infections that are resistant to the Sulphonamides |
Sulphasalazine .................. | Ulcerative colitis |
Sultiame ..................... | For use where other anticonvulsants have failed |
Surgical Cement ................ | Ileostomy or colostomy conditions |
Sustanon ..................... |
|
Testosterone Implants, B.P.......... |
|
Testosterone Oenanthate .......... |
|
Testosterone Propionate Injection, B.P.. | Castration syndrome (male and female) |
Klinefelter Reifenstein Albright syndrome | |
Methyltestosterone Tablets, B.P....... | Mammary carcinoma |
Methyltestosterone, B.P............ |
|
Tetracycline Capsules, B.P.......... |
|
Tetracycline Tablets, B.P........... |
|
Tetracycline Injections ............ |
|
Tetracycline Hydrochloride, with a buffering agent—Capsules and Injection |
A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus |
Rolitetracycline ................ | |
Tetracycline Granules ............ | |
Tetracycline Paediatric Drops ....... | |
Tetracycline Oral Suspension ....... |
|
Tetracycline with a buffering agent |
|
—Paediatric Drops |
|
Tetracycline with a buffering agent |
|
—Oral Suspension |
|
Tetracycline with a buffering agent and Amphotericin B | Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis |
A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus | |
Tetracycline with a buffering agent and Nystatin | |
Theophylline Elixir .............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
| Any disease or condition in a pensioner |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
| With the written authority of the Director-General— |
| Late-stage malignancy |
| Radiation sickness |
Thioridazine Tablets, B.P.... | With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
Thioridazine ............ | |
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride |
Thyrotrophin ........... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Tragacanth (Gum Karaya)... | Ileostomy or colostomy conditions |
Tretamine............. | Malignant lymphoma and related conditions |
Triamcinolone.......... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets |
Triamterene............ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Triaziquone............ | |
Trifluoperazine Tablets, B.P.. | Any disease or condition in a pensioner |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
| With the written authority of the Director-General— |
| Late-stage malignancy |
| Radiation sickness |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
| The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride or Imipramine Hydrochloride |
Trimetaphan Injection, B.P... | Hypotensive for anaesthesia |
Vadrine ............... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Vancomycin Hydrochloride . | |
Vasopressin Nasal Spray ... | Diabetes insipidus |
Velactin .............. | With the written authority of the Director-General— |
| Galactosaemia |
| Lactose intolerance |
| Milk allergy in children under the age of four years |
Fifth Schedule—continued
Pharmaceutical Benefits | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act |
Vinblastine Sulphate............. | Hodgkin’s disease |
Vincristine Sulphate.............. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Viomycin Sulphate.............. | |
Viomycin Sulphate Injection, B.P. | |
Viomycin Sulphate with Viomycin Pantothenate Combination | |
Vitamin A with Aneurine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D | Any disease or condition in a pensioner |
By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.